- Home
- ADAP vs RSSS Comparison
ADAP vs RSSS Comparison
Compare ADAP & RSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAP
- RSSS
- Stock Information
- Founded
- ADAP 2008
- RSSS 2006
- Country
- ADAP United Kingdom
- RSSS United States
- Employees
- ADAP 506
- RSSS N/A
- Industry
- ADAP Biotechnology: Pharmaceutical Preparations
- RSSS Business Services
- Sector
- ADAP Health Care
- RSSS Consumer Discretionary
- Exchange
- ADAP Nasdaq
- RSSS Nasdaq
- Market Cap
- ADAP 75.5M
- RSSS 88.2M
- IPO Year
- ADAP 2015
- RSSS N/A
- Fundamental
- Price
- ADAP $0.29
- RSSS $3.08
- Analyst Decision
- ADAP Strong Buy
- RSSS Strong Buy
- Analyst Count
- ADAP 5
- RSSS 1
- Target Price
- ADAP $1.83
- RSSS $6.00
- AVG Volume (30 Days)
- ADAP 777.8K
- RSSS 51.6K
- Earning Date
- ADAP 05-13-2025
- RSSS 05-08-2025
- Dividend Yield
- ADAP N/A
- RSSS N/A
- EPS Growth
- ADAP N/A
- RSSS N/A
- EPS
- ADAP N/A
- RSSS N/A
- Revenue
- ADAP $178,032,000.00
- RSSS $48,207,887.00
- Revenue This Year
- ADAP N/A
- RSSS $13.88
- Revenue Next Year
- ADAP $69.81
- RSSS $7.30
- P/E Ratio
- ADAP N/A
- RSSS N/A
- Revenue Growth
- ADAP 195.34
- RSSS 18.51
- 52 Week Low
- ADAP $0.20
- RSSS $2.32
- 52 Week High
- ADAP $1.48
- RSSS $4.24
- Technical
- Relative Strength Index (RSI)
- ADAP 51.38
- RSSS 66.75
- Support Level
- ADAP $0.30
- RSSS $2.72
- Resistance Level
- ADAP $0.32
- RSSS $2.94
- Average True Range (ATR)
- ADAP 0.02
- RSSS 0.11
- MACD
- ADAP 0.01
- RSSS 0.04
- Stochastic Oscillator
- ADAP 67.44
- RSSS 97.48
About ADAP Adaptimmune Therapeutics plc
Adaptimmune Therapeutics PLC is a commercial-stage biopharmaceutical company working to redefine the treatment of solid tumor cancers with cell therapies. It has developed a comprehensive proprietary platform that enables it to identify cancer targets, find and genetically engineer T-cell receptors, and produce TCR therapeutic candidates for administration to patients. Its programs include MAGE-A4 SPEAR T-cell therapy, NY-ESO SPEAR T-cell, CD70, and others for multiple cancer types.
About RSSS Research Solutions Inc
Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.